[Elsevier] CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)

Jay.2 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-21 04:44
Reward10points

journalㄩValue in Health

AuthorsㄩAnish Patel; Subrata Batabyal; Ramesh Arjunji; Samuel Barone; Samar Mohanty

Published dateㄩ2025-7-

DOIㄩ10.1016/j.jval.2025.04.135

PDF linkㄩhttps://www.sciencedirect.com/sc ... 098301525002591/pdf

Article linkㄩhttps://doi.org/10.1016/j.jval.2025.04.135

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Almis Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    60


Daily Top Contributors

Return to the list